When GlaxoSmithKline (GSK) exited Nigeria in late 2023, it left a major gap in the country’s pharmaceutical supply chain. One of the most affected products was Augmentin, GSK’s well-known brand of amoxicillin and clavulanate potassium. The antibiotic had long been a household name for treating bacterial infections.
After GSK’s exit, Nigeria turned almost entirely to imports to meet demand. Prices quickly spiralled. A pack of Augmentin 625
